Medscape | New Scoring System Evaluates Prognosis in Burkitt Lymphoma Medscape Adding rituximab to chemotherapy has improved both response and survival rates, but that has been difficult to conclusively demonstrate in small, single-arm, single-institution studies. Knowledge about the prognostic factors for survival in these ... |
